These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6165129)

  • 61. Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy.
    Bitran JD; Desser RK; Shapiro CM; Michel A; Kozloff MF; Billings AA; Recent W
    Cancer; 1983 Feb; 51(3):381-4. PubMed ID: 6821824
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Chemotherapy of non-Hodgkin lymphoma with poor prognosis].
    Rupniewska ZM; Kurowska M
    Pol Arch Med Wewn; 1980 Aug; 64(2):167-79. PubMed ID: 6159608
    [No Abstract]   [Full Text] [Related]  

  • 63. [Principle products used in chemotherapy. Administration methods].
    Boillon C; Olivro A; Lemerle J
    Soins; 1979 Aug 5-20; 24(15-16):51-9. PubMed ID: 90390
    [No Abstract]   [Full Text] [Related]  

  • 64. [Treatment of metastatic breast cancer].
    Yahalom J; Biran S; Sulkes A
    Harefuah; 1986 Jul; 111(1-2):8-11. PubMed ID: 2430868
    [No Abstract]   [Full Text] [Related]  

  • 65. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
    Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
    Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Antiblastic chemotherapy in the treatment of cancer of the prostate].
    Pavone-Macaluso M; Caramia G; Vecchioni M
    J Urol Nephrol (Paris); 1972; 78(7):621-34. PubMed ID: 4675962
    [No Abstract]   [Full Text] [Related]  

  • 67. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A; Cummings G; Al-Sarraf M
    Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of cyclophosphamide alone and scheduled methotrexate-5-fluorouracil combination chemotherapy on transplantable R-3327 prostatic adenocarcinoma in F1 hybrid male rat.
    Smith JB; Ghayad PY; Dhabuwala CB; Drelichman A; Pierce JM
    Urology; 1987 Aug; 30(2):143-6. PubMed ID: 3617298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
    Płuzańska A; Krykowski E; Robak T; Oliskiewicz W; Polkowska E; Dowgier I; Hyjek E
    Pol Tyg Lek; 1982 Sep; 37(36):1049-53. PubMed ID: 6189105
    [No Abstract]   [Full Text] [Related]  

  • 71. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 72. Mastectomy as an adjunct to combination chemotherapy.
    Morris D; Aisner J; Elias EG; Wiernik PH
    Arch Surg; 1978 Mar; 113(3):282-4. PubMed ID: 205189
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
    Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
    Cancer; 1983 Apr; 51(8):1348-52. PubMed ID: 6186356
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metastatic basal cell carcinoma: report of a case responding to chemotherapy.
    Woods RL; Stewart JF
    Postgrad Med J; 1980 Apr; 56(654):272-3. PubMed ID: 6159619
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer].
    Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
    Hinyokika Kiyo; 1991 Dec; 37(12):1657-62. PubMed ID: 1723841
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Combination chemotherapy with methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, and bleomycin: MVP-CAB for disseminated urological cancer].
    Fujii A; Morishita S; Nakamura I; Oka Y; Ohshima H; Nagata H; Iwamoto T; Itoh N; Nakagawa Y; Miyazaki S
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):55-62. PubMed ID: 1691254
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate.
    Berry WR; Laszlo J; Cox E; Walker A; Paulson D
    Cancer; 1979 Aug; 44(2):763-75. PubMed ID: 476583
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
    Rodgers RW; Gamble JF; Loh KK; Shullenberger CC
    Cancer; 1980 Dec; 46(11):2349-55. PubMed ID: 6159961
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bleomycin combination chemotherapy in the management of testicular neoplasia.
    Samuels ML; Holoye PY; Johnson DE
    Cancer; 1975 Aug; 36(2):318-26. PubMed ID: 50869
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.